16 May, 12:49 - Indian

SENSEX 82310.89 (-0.27)

Nifty 50 25002.7 (-0.24)

Nifty Bank 55312.2 (-0.08)

Nifty IT 37953.1 (-0.89)

Nifty Midcap 100 57102.5 (1.01)

Nifty Next 50 67049.3 (1.24)

Nifty Pharma 21648.1 (-0.01)

Nifty Smallcap 100 17538.55 (1.73)

16 May, 12:49 - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23353.1 (-0.43)

S&P 5948 (0.05)


Stock Alert News

You are Here : Home > News > Stock Alert News >

(07 Mar 2025, 08:31)

Stock Alert: TCS, Power Grid Corporation, NMDC, Biocon, Firstsource Solutions


Securities in F&O Ban:

Manappuram Finance shares are banned from F&O trading on 7 March 2025.

Stocks to Watch:

Tata Consultancy Services (TCS) has signed an expanded deal with Northern Trust, a global financial institution, to centralize and standardize its custody operations across 99 direct and global markets. TCS will deploy its comprehensive TCS BaNCS Global Securities Platform for Northern Trust, which has $17.4 trillion in assets under custody and administration as of December 2024.

Power Grid Corporation of India has been declared the successful bidder to establish an inter-state transmission system in Andhra Pradesh. It has received a Letter of Intent for the project, which comprises the augmentation of transformation capacity at the existing Kurnool-III substation and extension works at the existing C’peta substation, along with a 765kV D/C transmission line.

NMDC informed that government of India has appointed Amitava Mukherjee as chairman & managing director (CMD), effective from 6 March 2025.

Sudarshan Pharma Industries announced that Sachin Mehta has resigned as chief financial officer of the company, effective April 1, 2025. However, he will continue as the joint managing director of the company. The Board has appointed Manoj Lodha as executive director and chief financial officer of the company, effective April 1.

Biocon’s subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., which will use the drug substance to produce Insulin Aspart drug products, a rapid-acting insulin analog, at its manufacturing facility in Petersburg, Virginia.

FirstSource Solutions launched its Agentic AI Studio, a solution designed to transform the future of work.

Kalpataru Projects International bagged new orders worth Rs 2,306 crore for transmission and distribution business in overseas markets and building projects in India.

Quality Power Electrical Equipments has acquired 51% of the share capital of Mehru Electrical and Mechanical Engineers for a total cash consideration of Rs 120 crore, through a share purchase agreement.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +